AstraZeneca Advances Response to Global COVID-19 Challenge as it Receives First Commitments for Oxford ’s Potential New Vaccine

21 May 2020 -- AstraZeneca is advancing its ongoing response to address the unprecedented challenges of COVID-19, collaborating with a number of countries and multilateral organisations to make the University of Oxford’s vaccine widely...
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials